These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 26708684

  • 1. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Jan 03; 157(1):30-4. PubMed ID: 26708684
    [Abstract] [Full Text] [Related]

  • 2. [Medication adherence with the fixed combination of ramipril and amlodipine].
    Simonyi G, Ferenci T.
    Orv Hetil; 2014 Nov 23; 155(47):1882-8. PubMed ID: 25403283
    [Abstract] [Full Text] [Related]

  • 3. [One year adherence of ramipril versus ramipril/amlodipine fixed dose combination therapy in hypertension].
    Simonyi G, Ferenci T.
    Orv Hetil; 2017 Oct 23; 158(42):1669-1673. PubMed ID: 29037057
    [Abstract] [Full Text] [Related]

  • 4. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Mar 13; 157(11):425-9. PubMed ID: 26947091
    [Abstract] [Full Text] [Related]

  • 5. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.
    Orv Hetil; 2019 Mar 13; 160(9):343-348. PubMed ID: 30798621
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Apr 17; 157(16):618-22. PubMed ID: 27063429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 17; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 17; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 13. Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
    Perrone V, Veronesi C, Gambera M, Nati G, Perone F, Tagliabue PF, Degli Esposti L, Volpe M.
    High Blood Press Cardiovasc Prev; 2019 Oct 17; 26(5):399-404. PubMed ID: 31463886
    [Abstract] [Full Text] [Related]

  • 14. [Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy].
    Simonyi G, Ferenci T.
    Orv Hetil; 2015 Jan 25; 156(4):141-5. PubMed ID: 25597318
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Jan 25; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 17. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 18. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE, Martynyuk TV.
    Ter Arkh; 2013 Apr 25; 85(9):35-45. PubMed ID: 24261228
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM, Yan LR, Tao YK, Wang L, Li YQ, Gao MM, Wang YN, Li CX, Wang XW, Lu XL, Pang HM, Li YS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan 25; 39(1):57-60. PubMed ID: 21418799
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome].
    Shevchenko OP, Praskurnichiĭ EA, Savel'eva SA.
    Ter Arkh; 2008 Jan 25; 80(4):54-9. PubMed ID: 18491582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.